These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30214604)

  • 61. Disturbed Transcription of TLRs' Negative Regulators and Cytokines Secretion among TLR4- and 9-Activated PBMCs of Agammaglobulinemic Patients.
    Sanaei R; Rezaei N; Aghamohammadi A; Delbandi AA; Tavasolian P; Tajik N
    Immunol Invest; 2019 Nov; 48(8):860-874. PubMed ID: 31185757
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Decreased Interleukin-1 Family Cytokine Production in Patients with Nontuberculous Mycobacterial Lung Disease.
    Jung BG; Dean K; Wadle C; Samten B; Tripathi D; Wallace RJ; Brown-Elliott BA; Tucker T; Idell S; Philley JV; Vankayalapati R
    Microbiol Spectr; 2022 Dec; 10(6):e0311022. PubMed ID: 36255321
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interleukin-21 enhances Toll-like receptor 2/4-mediated cytokine production via phosphorylation in the STAT3, Akt and p38 MAPK signalling pathways in human monocytic THP-1 cells.
    Jian L; Sun L; Li C; Yu R; Ma Z; Wang X; Zhao J; Liu X
    Scand J Immunol; 2019 Jun; 89(6):e12761. PubMed ID: 30977163
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Generation of T cell-mediated antitumor response in vitro by autologous dendritic cells pulsed with tumor lysates in patients with non-small cell lung cancer].
    You J; Yu JP; Ren XB; Wang CL; Zhang P; Zhang XZ
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):333-6. PubMed ID: 15312341
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Increased activation of toll-like receptors-7 and -8 of peripheral blood mononuclear cells and upregulated serum cytokines in patients with pediatric systemic lupus erythematosus.
    Guo Y; Chai Q; Zhao Y; Li P; Qiao J; Huang J
    Int J Clin Exp Med; 2015; 8(11):20472-80. PubMed ID: 26884963
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Toll-like receptor agonists partially restore the production of pro-inflammatory cytokines and type I interferon in Sézary syndrome.
    Manfrere KC; Torrealba MP; Miyashiro DR; Oliveira LM; de Carvalho GC; Lima JF; Branco AC; Pereira NZ; Pereira J; Sanches JA; Sato MN
    Oncotarget; 2016 Nov; 7(46):74592-74601. PubMed ID: 27780938
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expression levels of cytokines and chemokines increase in human peripheral blood mononuclear cells stimulated by activation of the Toll-like receptor 5 pathway.
    Ma YU; Zhang LI; Li Q
    Exp Ther Med; 2016 Feb; 11(2):588-592. PubMed ID: 26893651
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
    Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
    Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of Berberine on Activation of TLR4-NFκB Signaling Pathway and NLRP3 Inflammasome in Patients with Gout.
    Dang WT; Xu D; Zhou JG
    Chin J Integr Med; 2023 Jan; 29(1):10-18. PubMed ID: 36125615
    [TBL] [Abstract][Full Text] [Related]  

  • 70. HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response.
    Codolo G; Fassan M; Munari F; Volpe A; Bassi P; Rugge M; Pagano F; D'Elios MM; de Bernard M
    Cancer Immunol Immunother; 2012 Jan; 61(1):31-40. PubMed ID: 21833592
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade.
    Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs.
    Lyn-Cook BD; Xie C; Oates J; Treadwell E; Word B; Hammons G; Wiley K
    Mol Immunol; 2014 Sep; 61(1):38-43. PubMed ID: 24865418
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Molecular mechanisms of HBeAg in persistent HBV infection.
    Chen LM; Fan XG; Ma J; He B; Jiang YF
    Hepatol Int; 2017 Jan; 11(1):79-86. PubMed ID: 27193024
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Enhanced interleukin-1β production of PBMCs from patients with gout after stimulation with Toll-like receptor-2 ligands and urate crystals.
    Mylona EE; Mouktaroudi M; Crisan TO; Makri S; Pistiki A; Georgitsi M; Savva A; Netea MG; van der Meer JW; Giamarellos-Bourboulis EJ; Joosten LA
    Arthritis Res Ther; 2012 Jul; 14(4):R158. PubMed ID: 22762240
    [TBL] [Abstract][Full Text] [Related]  

  • 76. IFN-γ stimulates CpG-induced IL-10 production in B cells via p38 and JNK signalling pathways.
    Imbrechts M; De Samblancx K; Fierens K; Brisse E; Vandenhaute J; Mitera T; Libert C; Smets I; Goris A; Wouters C; Matthys P
    Eur J Immunol; 2018 Sep; 48(9):1506-1521. PubMed ID: 30004580
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation.
    Müller E; Speth M; Christopoulos PF; Lunde A; Avdagic A; Øynebråten I; Corthay A
    Front Immunol; 2018; 9():2520. PubMed ID: 30450098
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Effect of interleukin-7 on the anti-tumor function of CD8(+) T cells in patients with non-small cell lung cancer].
    Zhang XH; Wang HM; Jin L; Chang R; Zu FC; Li FZ; Ku CY
    Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(30):2429-2433. PubMed ID: 30138989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.